These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25714906)

  • 1. Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives.
    Miller JD; Lenhart GM; Bonafede MM; Lukes AS; Laughlin-Tommaso SK
    Popul Health Manag; 2015 Oct; 18(5):373-82. PubMed ID: 25714906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Evaluation of Global Endometrial Ablation Versus Inpatient and Outpatient Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives.
    Miller JD; Bonafede MM; Cai Q; Pohlman SK; Troeger KA; Cholkeri-Singh A
    Popul Health Manag; 2018 Mar; 21(S1):S1-S12. PubMed ID: 29570003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.
    Miller JD; Lenhart GM; Bonafede MM; Basinski CM; Lukes AS; Troeger KA
    Int J Womens Health; 2015; 7():59-73. PubMed ID: 25610002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of direct and indirect costs of abnormal uterine bleeding treatment with global endometrial ablation and hysterectomy.
    Bonafede MM; Miller JD; Lukes A; Meyer NM; Lenhart GM
    J Comp Eff Res; 2015 Mar; 4(2):115-22. PubMed ID: 25496448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employer-perspective cost comparison of surgical treatments for abnormal uterine bleeding.
    Miller JD; Bonafede MM; Pohlman SK; Cholkeri-Singh A; Troeger KA
    J Comp Eff Res; 2020 Jan; 9(1):67-77. PubMed ID: 31773992
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of treatments for heavy menstrual bleeding.
    Spencer JC; Louie M; Moulder JK; Ellis V; Schiff LD; Toubia T; Siedhoff MT; Wheeler SB
    Am J Obstet Gynecol; 2017 Nov; 217(5):574.e1-574.e9. PubMed ID: 28754438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Payer cost savings with endometrial ablation therapy.
    London R; Holzman M; Rubin D; Moffitt B
    Am J Manag Care; 1999 Jul; 5(7):889-97. PubMed ID: 10557409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs.
    Bonafede MM; Miller JD; Laughlin-Tommaso SK; Lukes AS; Meyer NM; Lenhart GM
    Clinicoecon Outcomes Res; 2014; 6():423-9. PubMed ID: 25336979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial ablation in the management of abnormal uterine bleeding.
    Laberge P; Leyland N; Murji A; Fortin C; Martyn P; Vilos G; ; Leyland N; Wolfman W; Allaire C; Awadalla A; Dunn S; Heywood M; Lemyre M; Marcoux V; Potestio F; Rittenberg D; Singh S; Yeung G;
    J Obstet Gynaecol Can; 2015 Apr; 37(4):362-79. PubMed ID: 26001691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis.
    Bhattacharya S; Middleton LJ; Tsourapas A; Lee AJ; Champaneria R; Daniels JP; Roberts T; Hilken NH; Barton P; Gray R; Khan KS; Chien P; O'Donovan P; Cooper KG; ; Abbott J; Barrington J; Bhattacharya S; Bongers MY; Brun JL; Busfield R; Clark TJ; Cooper J; Cooper KG; Corson SL; Dickersin K; Dwyer N; Gannon M; Hawe J; Hurskainen R; Meyer WR; O'Connor H; Pinion S; Sambrook AM; Tam WH; van Zon-Rabelink IA; Zupi E
    Health Technol Assess; 2011 Apr; 15(19):iii-xvi, 1-252. PubMed ID: 21535970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis.
    Roberts TE; Tsourapas A; Middleton LJ; Champaneria R; Daniels JP; Cooper KG; Bhattacharya S; Barton PM
    BMJ; 2011 Apr; 342():d2202. PubMed ID: 21521730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surgical treatment of idiopathic abnormal uterine bleeding: An analysis of 88 000 patients from the French exhaustive national hospital discharge database from 2009 to 2015.
    de Léotoing L; Chaize G; Fernandes J; Toth D; Descamps P; Dubernard G; Lafon T; Lamarsalle L; Fernandez H
    PLoS One; 2019; 14(6):e0217579. PubMed ID: 31185019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids.
    Harrington A; Bonine NG; Banks E; Shih V; Stafkey-Mailey D; Fuldeore RM; Yue B; Ye JM; Ta JT; Gillard P
    J Manag Care Spec Pharm; 2020 Jan; 26(1-a Suppl):S2-S10. PubMed ID: 31958025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT.
    Cooper K; Breeman S; Scott NW; Scotland G; Hernández R; Clark TJ; Hawe J; Hawthorn R; Phillips K; Wileman S; McCormack K; Norrie J; Bhattacharya S
    Health Technol Assess; 2019 Sep; 23(53):1-108. PubMed ID: 31577219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the levonorgestrel-releasing intrauterine system, hysterectomy, and endometrial ablation for heavy menstrual bleeding in a decision analysis model.
    Louie M; Spencer J; Wheeler S; Ellis V; Toubia T; Schiff LD; Siedhoff MT; Moulder JK
    Int J Gynaecol Obstet; 2017 Nov; 139(2):121-129. PubMed ID: 28796898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global endometrial ablation.
    Biscette S; Shepherd J; Pasic RP
    Surg Technol Int; 2010 Oct; 20():208-13. PubMed ID: 21082568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative costs of gynecologic endoscopy vs traditional surgery for treatment of abnormal uterine bleeding.
    Hidlebaugh DA
    Am J Manag Care; 2001 Sep; 7 Spec No():SP31-7. PubMed ID: 11599673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of treatments for dysfunctional uterine bleeding.
    Wade SW; Magee G; Metz L; Broder MS
    J Reprod Med; 2006 Jul; 51(7):553-62. PubMed ID: 16913546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding.
    Matteson KA; Abed H; Wheeler TL; Sung VW; Rahn DD; Schaffer JI; Balk EM;
    J Minim Invasive Gynecol; 2012; 19(1):13-28. PubMed ID: 22078015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.